(Q48379599)

11 February 2018

title

A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics (English)

1 reference

11 February 2018

1 reference

Roberts JT

1

1 reference

11 February 2018

Bleehen NM

series ordinal

2

1 reference

11 February 2018

Walton MI

series ordinal

3

1 reference

11 February 2018

Workman P

series ordinal

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 February 1986

1 reference

11 February 2018

British Journal of Radiology

published in

1 reference

11 February 2018

volume

59

1 reference

11 February 2018

issue

698

1 reference

11 February 2018

page(s)

107-116

1 reference

11 February 2018

Human studies with "high dose" metronidazole: a non-toxic radiosensitizer of hypoxic cells

cites work

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

In vivo assessment of basic 2-nitroimidazole radiosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

Misonidazole Combined with Split-Course Radiotherapy in the Treatment of Invasive Carcinoma of the Larynx and the Pharynx - A Preliminary Report of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2F0007-1285-59-698-107

10.1259/0007-1285-59-698-107

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018